...

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Elacestrant (RAD1901) inhibits growth of ex vivo cultured circulating tumor cells derived from hormone receptor-positive metastatic breast cancer (mBC) patients including those harboring ESR1 mutations

【24h】

Elacestrant (RAD1901) inhibits growth of ex vivo cultured circulating tumor cells derived from hormone receptor-positive metastatic breast cancer (mBC) patients including those harboring ESR1 mutations

机译：诸rad1901）抑制来自激素受体阳性转移性乳腺癌（MBC）患者的离体培养循环肿瘤细胞的生长，包括患ESR1突变的患者

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Elacestrant (RAD1901) inhibits growth of ex vivo cultured circulating tumor cells derived from hormone receptor-positive metastatic breast cancer (mBC) patients including those harboring ESR1 mutations [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：诸rad1901）抑制来自激素受体阳性转移性乳腺癌（MBC）患者的离体培养循环肿瘤细胞的生长，包括患ESR1突变的患者
2. Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients [J] . Franken Andre, Honisch Ellen, Reinhardt Florian, The Journal of molecular diagnostics: JMD . 2020,第1期

机译：雌激素剥夺疗法对单循环肿瘤细胞ESR1突变的检测，但在转移性腔乳腺癌患者的原发性肿瘤中
3. A phase 1b study of the CDK4/6 inhibitor ribociclib in combination with the PD-1 inhibitor spartalizumab in patients with hormone receptor-positive metastatic breast cancer (HR plus MBC) and metastatic ovarian cancer (MOC) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：CDK4 / 6抑制剂Ribociclib与激素受体阳性转移性乳腺癌（HR加MBC）和转移性卵巢癌（MOC）组合的CDK4 / 6抑制剂核酸核酸核苷酸的第1B期研究
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Toll-like receptor (TLR) expression and function of immune system cells from metastatic breast cancer patients with circulating tumor cells. [D] . Green, Taryn Lindsey. 2013

机译：Toll样受体（TLR）的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
6. ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis [O] . Loredana Urso, Grazia Vernaci, Jessica Carlet, 2021

机译：激素受体阳性HER2阴性转移性乳腺癌患者的ESR1基因突变：肿瘤组织和循环肿瘤DNA分析之间的一致性
7. Patients with metastatic hormone receptor-positive breast cancer express PIK3CA oncogene mutational heterogeneity in circulating tumor cells [O] . Bram De Laere, Dieter JE Peeters, Anja Brouwer, 2016

机译：转移激素受体阳性乳腺癌表达Pik3CA癌症患者循环肿瘤细胞中的患者

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号